跳转到主要内容
搜索

早期临床

注册

最新资源

精选资源

Upcoming early clinical webinars

网络研讨会

Model Smarter, Not Harder: Introducing Model Designer

2026 年 6 月 30 日, 10:00 – 11:00 AM ET | 2026 年 7 月 2 日, 10:00 – 11:00 AM JST & 10:00 –
网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 7 月 7 日 – 10-11 AM ET/CET/JST
网络研讨会

Building IND-Ready and Investor-Ready Development Programs

2026 年 7 月 9 日 – 10:00 - 11:00am ET

Latest early clinical blogs

在以下活动中与我们的专家会面

All early clinical resources

Quantitative Prediction of Formulation-specific Food Effects and Their Population Variability from In Vitro Data Using the Physiologically-based ADAM Model: A Case Study Using BCS/BDDCS Class II Drug Nifedipine.

Model Informed Drug Development, pre-update, Publication

Conversion from Twice- to Once-daily Tacrolimus in Pediatric Kidney Recipients: A Pharmacokinetic and Bioequivalence Study

Pediatrics, pre-update, Therapeutic Specialties, Publication

The ISoP Standards and Best Practices Committee

Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Publication

What Can We Learn from Dose Normalization?

Modeling and Simulation - PK/PD, Blog, Knowledge Base

Improving the Assessment of Heart Toxicity for All New Drugs Through Translational Regulatory Science

Model Informed Drug Development, pre-update, Publication

Changes in Individual Drug-independent System Parameters during Virtual Pediatric Pharmacokinetic Trials: Introducing Time-varying Physiology into a Pediatric PBPK Model

Model Informed Drug Development, Pediatrics, pre-update, Therapeutic Specialties, Publication

Physiologically-based Pharmacokinetic Modeling Framework for Quantitative Prediction of an Herb–Drug Interaction

Modeling and Simulation - PK/PD, pre-update, Publication

Population Pharmacokinetics of Azithromycin in Whole Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells in Healthy Adults

Infectious Disease, Model Informed Drug Development, Modeling and Simulation - PK/PD, Oncology/Hematology, pre-update, Therapeutic Specialties, Publication

Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc Studies

Model Informed Drug Development, Modeling and Simulation - PK/PD, pre-update, Publication

Electrocardiographic Data Quality in Thorough QT/QTc Studies

Model Informed Drug Development, pre-update, Publication

In Vitro-In Vivo Extrapolation of Drug-induced Proarrhythmia Predictions at the Population Level

Model Informed Drug Development, pre-update, Publication

Precision Criteria to Derive Sample Size When Designing Pediatric Pharmacokinetics Studies: Which Measure of Variability Should be Used?

Model Informed Drug Development, Pediatrics, pre-update, Therapeutic Specialties, Publication
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software